454 related articles for article (PubMed ID: 19594841)
21. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
[TBL] [Abstract][Full Text] [Related]
22. Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections?
Benecke R; Heinze A; Reichel G; Hefter H; Göbel H;
Pain Med; 2011 Nov; 12(11):1607-14. PubMed ID: 21692970
[TBL] [Abstract][Full Text] [Related]
23. Treatment of chronic low back pain with successive injections of botulinum toxin a over 6 months: a prospective trial of 60 patients.
Ney JP; Difazio M; Sichani A; Monacci W; Foster L; Jabbari B
Clin J Pain; 2006 May; 22(4):363-9. PubMed ID: 16691090
[TBL] [Abstract][Full Text] [Related]
24. The effect of 300 mW, 830 nm laser on chronic neck pain: a double-blind, randomized, placebo-controlled study.
Chow RT; Heller GZ; Barnsley L
Pain; 2006 Sep; 124(1-2):201-10. PubMed ID: 16806710
[TBL] [Abstract][Full Text] [Related]
25. Botulinum toxin A for neuropathic pain after neck dissection: a dose-finding study.
Wittekindt C; Liu WC; Preuss SF; Guntinas-Lichius O
Laryngoscope; 2006 Jul; 116(7):1168-71. PubMed ID: 16826054
[TBL] [Abstract][Full Text] [Related]
26. Botulinum toxin type A for the treatment of chronic neck pain after neck dissection.
Vasan CW; Liu WC; Klussmann JP; Guntinas-Lichius O
Head Neck; 2004 Jan; 26(1):39-45. PubMed ID: 14724905
[TBL] [Abstract][Full Text] [Related]
27. Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.
Yuan RY; Sheu JJ; Yu JM; Chen WT; Tseng IJ; Chang HH; Hu CJ
Neurology; 2009 Apr; 72(17):1473-8. PubMed ID: 19246421
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study.
Truong D; Duane DD; Jankovic J; Singer C; Seeberger LC; Comella CL; Lew MF; Rodnitzky RL; Danisi FO; Sutton JP; Charles PD; Hauser RA; Sheean GL
Mov Disord; 2005 Jul; 20(7):783-91. PubMed ID: 15736159
[TBL] [Abstract][Full Text] [Related]
29. The efficacy and safety of a new U.S. Botulinum toxin type A in the retreatment of glabellar lines following open-label treatment.
Rubin MG; Dover J; Glogau RG; Goldberg DJ; Goldman MP; Schlessinger J
J Drugs Dermatol; 2009 May; 8(5):439-44. PubMed ID: 19537366
[TBL] [Abstract][Full Text] [Related]
30. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.
Harden RN; Cottrill J; Gagnon CM; Smitherman TA; Weinland SR; Tann B; Joseph P; Lee TS; Houle TT
Headache; 2009 May; 49(5):732-43. PubMed ID: 19178577
[TBL] [Abstract][Full Text] [Related]
31. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.
Jongerius PH; van den Hoogen FJ; van Limbeek J; Gabreëls FJ; van Hulst K; Rotteveel JJ
Pediatrics; 2004 Sep; 114(3):620-7. PubMed ID: 15342830
[TBL] [Abstract][Full Text] [Related]
32. Is botulinum toxin A effective for the treatment of plantar fasciitis?
Peterlein CD; Funk JF; Hölscher A; Schuh A; Placzek R
Clin J Pain; 2012 Jul; 28(6):527-33. PubMed ID: 22673486
[TBL] [Abstract][Full Text] [Related]
33. A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches.
Relja M; Poole AC; Schoenen J; Pascual J; Lei X; Thompson C;
Cephalalgia; 2007 Jun; 27(6):492-503. PubMed ID: 17428299
[TBL] [Abstract][Full Text] [Related]
34. Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin.
Gazerani P; Pedersen NS; Staahl C; Drewes AM; Arendt-Nielsen L
Pain; 2009 Jan; 141(1-2):60-9. PubMed ID: 19004549
[TBL] [Abstract][Full Text] [Related]
35. The efficacy of oxycodone for management of acute pain episodes in chronic neck pain patients.
Ma K; Jiang W; Zhou Q; Du DP
Int J Clin Pract; 2008 Feb; 62(2):241-7. PubMed ID: 18070045
[TBL] [Abstract][Full Text] [Related]
36. Botulinum toxin type-a in the prevention of migraine: a double-blind controlled trial.
Vo AH; Satori R; Jabbari B; Green J; Killgore WD; Labutta R; Campbell WW
Aviat Space Environ Med; 2007 May; 78(5 Suppl):B113-8. PubMed ID: 17547312
[TBL] [Abstract][Full Text] [Related]
37. Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial.
Sahai A; Dowson C; Khan MS; Dasgupta P
BJU Int; 2009 Jun; 103(11):1509-15. PubMed ID: 19389019
[TBL] [Abstract][Full Text] [Related]
38. Neuro-reflexotherapy for the management of myofascial temporomandibular joint pain: a double-blind, placebo-controlled, randomized clinical trial.
Berguer A; Kovacs F; Abraira V; Mufraggi N; Royuela A; Muriel A; Gestoso M; Falahat F; Martín-Granizo R; Zamora J
J Oral Maxillofac Surg; 2008 Aug; 66(8):1664-77. PubMed ID: 18634956
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of botulinum toxin type A in the treatment of lateral crow's feet: double-blind, placebo-controlled, dose-ranging study.
Ascher B; Rzany BJ; Grover R
Dermatol Surg; 2009 Oct; 35(10):1478-86. PubMed ID: 19686365
[TBL] [Abstract][Full Text] [Related]
40. Management of shoulder and proximal upper limb spasticity using botulinum toxin and concurrent therapy interventions: a preliminary analysis of goals and outcomes.
Ashford S; Turner-Stokes L
Disabil Rehabil; 2009; 31(3):220-6. PubMed ID: 18608366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
